This indicates that hypermethylation did not considerably contribute to NF2 gene silencing in these patients, suggesting that alternative mechanisms such as mutations or deletions have a more crucial role in tumour development in NF2-related VSs. This evidence concerns the gene NF2 and neoplasm.